Search results
Results from the WOW.Com Content Network
Ovarian remnant syndrome [1] is a condition that occurs when ovarian tissue is left behind following oophorectomy, causing development of a pelvic mass, pelvic pain, and occasionally dyspareunia. [2] Ovarian remnant syndrome (ORS) is characterized by the presence of residual ovarian tissue after a woman has had surgery to remove one ovary or ...
However, diabetes does cause higher morbidity, mortality and operative risks with these conditions. [41] Diabetic foot, often due to a combination of sensory neuropathy (numbness or insensitivity) and vascular damage, increases rates of skin ulcers (diabetic foot ulcers) and infection and, in serious cases, necrosis and gangrene. It is why it ...
Of those who are postmenopausal and have developed atrophic vaginitis, 50-70% develop symptoms. [1] [23] Around 30% of women with atrophic vaginitis discuss their symptoms with their primary healthcare provider. It is likely to be under diagnosed and under treated due to lack of awareness of those who are affected by atrophic vaginitis and of ...
Vulvovaginal atrophy is thinning, drying, and inflammation of the vaginal walls that can happen when your body produces less estrogen, most commonly after menopause (usually in women 50 or over ...
The ovarian fibroma, also fibroma, is a benign sex cord-stromal tumour. Ovarian fibromas represent 4% of all ovarian neoplasms. [ 1 ] They tend to occur mostly during perimenopause and postmenopause , the median age having been reported to be about 52 years, and they are rare in children . [ 1 ]
Here, an OB/GYN specializing in menopause explains how nutrient needs change during menopause. Plus, find out the one nutrient women need less of as they enter the post-menopausal stage.
There are four types of ovarian cysts — functional cysts, PCOS cysts, benign ovarian tumor and malignant ovarian tumor — that range from harmless to fatal.
In efforts to encourage women to participate in clinical research, the National Institute of Health (NIH) launched the women's health initiative in 1991 that focuses clinical trials and observational studies on post-menopausal women over a 15 year period of time.